RTTNews | Sep 1, 2021 10:50AM EDT

10:50 Wednesday, September 1, 2021 (RTTNews.com) - Shares of Evaxion Biotech A/S (EVAX) are gaining over 16% on Wednesday morning despite no stock-related news to drive the shares.

EVAX is currently trading at $7.59, up $1.06 or 16.25%, on the Nasdaq, on a volume of 2.0 million shares, far above average volume of 75 thousand shares. The stock has traded between $5.16 and $10.34 in the 52-week period. Since August 20, the stock has been on rally and has gained nearly 50%.

Evaxion Biotech, a clinical-stage artificial intelligence-immunology platform company, identifies and develops novel immunotherapies for the treatment of various cancers, bacterial diseases, and viral infections.

Read the original article on RTTNews ( https://www.rttnews.com/3222626/evaxion-biotech-rally-continues-shares-gain-16.aspx)

For comments and feedback: contact editorial@rttnews.com

Copyright(c) 2021 RTTNews.com All Rights Reserved